AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Early Endotoxin Burden Reduction With oXiris in Septic Shock Patients Requiring CRRT

RecruitingNAAges 18 Years - anyAllSun Yat-Sen Memorial Hospital of Sun Yat-Sen Univโ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn whether continuous renal replacement therapy (CRRT) using the oXiris filter can lower the amount of endotoxin in the blood of adults with septic shock who need CRRT. Septic shock is a life-threatening condition caused by infection and severe organ dysfunction. CRRT is a form of continuous blood purification used to support the kidneys and manage fluid and waste products. The oXiris filter is designed to provide CRRT while also removing endotoxin and inflammatory substances from the blood. The main questions this study aims to answer are: Does 24 hours of CRRT with the oXiris filter lower blood endotoxin levels compared with levels before treatment? What changes occur in inflammation, organ function, and the need for medicines that raise blood pressure? What medical problems or treatment-related complications occur during the study? This is a

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older. * Diagnosis of septic shock according to Sepsis-3 criteria: sepsis with persistent hypotension requiring vasopressors to maintain a mean arterial pressure of at least 65 mmHg and a blood lactate level greater than 2 mmol/L despite adequate fluid resuscitation. * Acute kidney injury classified as KDIGO stage 2 or 3. * A clinical decision by the treating team to initiate continuous renal replacement therapy (CRRT). Exclusion Criteria: * The decision to initiate CRRT was made 24 hours or more before enrollment. * A documented decision to limit life-sustaining treatment or not to pursue invasive treatment. * Active major bleeding, a major bleeding event within the previous 48 hours, or severe uncorrected bleeding tendency. * Confirmed or suspected heparin-induced thrombocytopenia, or a known severe allergy to heparin or the filter materials. * Severe irreversible end-stage organ failure with an expected survival of 48 hours or less. * Pregnancy or breastfeeding. * Participation within the previous 6 months in another interventional study that may affect the outcomes of this study. * Written informed consent not obtained from the participant or legally authorized representative.
๐Ÿ’Š

What it tests

  • oXiris Hemofilter
๐Ÿ“

Where

1 site
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy